Clinical Trial Update: Open-label Milnacipran for Persistent Knee Pain One Year After Total Knee Arthroplasty (TKA) [Phase 4]

View source ↗

Summary

Open-label Phase 4 study evaluating milnacipran for persistent knee pain one year after total knee arthroplasty; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Pain After Total Knee Arthroplasty
• Osteoarthritis

Drugs mentioned

• Milnacipran (milnacipran)

Snippet

Sponsor: Duke University | Conditions: Knee Pain After Total Knee Arthroplasty, Osteoarthritis Pain | Phase 4 | Status: COMPLETED | Results posted: 2014-05-23